期刊
BIOMATERIALS
卷 34, 期 35, 页码 8909-8917出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2013.07.099
关键词
ssDNA aptamer; CD30; Lymphoma; ALCL; cHL; Cancer immunotherapy
资金
- NIH [R01CA151955, R33CA173382, 5P50CAl26752]
CD30 is highly expressed on Hodgkins lymphoma and anaplastic large cell lymphoma, making it an attractive target for therapy. We describe the generation of serum-stabilized ssDNA aptamers that bind CD30 via a hybrid SELEX methodology. The selected aptamer bound CD30 with high affinity and specificity. Further optimization of the aptamer led to a short, truncated variant with a 50-fold higher affinity than its longer counterpart. The multivalent aptamer was able to induce oligomerization of CD30 receptors and, in effect, activate downstream signaling, which led to apoptosis of ALCL cells. Immunotherapy using aptamer-based co-stimulation provides an alternative to antibodies, and has potential to transform cancer treatment. (C) 2013 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据